TY - JOUR
T1 - Repair of segmental long-bone defects by stem cell concentrate augmented scaffolds
T2 - A clinical and positron emission tomography - Computed tomography analysis
AU - Petri, Maximilian
AU - Namazian, Ali
AU - Wilke, Florian
AU - Ettinger, Max
AU - Stübig, Timo
AU - Brand, Stephan
AU - Bengel, Frank
AU - Krettek, Christian
AU - Berding, Georg
AU - Jagodzinski, Michael
PY - 2013/11
Y1 - 2013/11
N2 - Purpose: Treating segmental long-bone defects remains a major challenge. For defects >3 cm, segmental transport represents the gold standard, even though the method is time consuming and afflicted with several complications. The aim of this study was to evaluate healing of such defects after grafting an osteogenic scaffold previously seeded with stem cell concentrate. Methods: We evaluated five patients with segmental long-bone defects (3-14 cm) treated with bone marrow aspirate concentrates (BMAC) seeded onto a bovine xenogenous scaffold. The healing process was monitored by X-rays and positron emission tomography-computed tomography (PET-CT) three months after surgery. Results: Centrifugation led to a concentration of leukocytes by factor 8.1 ± 7.5. Full weight bearing was achieved 11.3 ± 5.0 weeks after surgery. PET analysis showed an increased influx of fluoride by factor 8.3 ± 6.4 compared with the contralateral side (p < 0.01). Bone density in the cortical area was 75 ± 16 % of the contralateral side (p < 0.03). The patient with the largest defect sustained an implant failure in the distal femur and finally accomplished therapy by segmental transport. He also had the lowest uptake of fluoride of the patient collective (2.2-fold increase). Conclusion: Stem cell concentrates can be an alternative to segmental bone transport. Further studies are needed to compare this method with autologous bone grafting and segmental transport.
AB - Purpose: Treating segmental long-bone defects remains a major challenge. For defects >3 cm, segmental transport represents the gold standard, even though the method is time consuming and afflicted with several complications. The aim of this study was to evaluate healing of such defects after grafting an osteogenic scaffold previously seeded with stem cell concentrate. Methods: We evaluated five patients with segmental long-bone defects (3-14 cm) treated with bone marrow aspirate concentrates (BMAC) seeded onto a bovine xenogenous scaffold. The healing process was monitored by X-rays and positron emission tomography-computed tomography (PET-CT) three months after surgery. Results: Centrifugation led to a concentration of leukocytes by factor 8.1 ± 7.5. Full weight bearing was achieved 11.3 ± 5.0 weeks after surgery. PET analysis showed an increased influx of fluoride by factor 8.3 ± 6.4 compared with the contralateral side (p < 0.01). Bone density in the cortical area was 75 ± 16 % of the contralateral side (p < 0.03). The patient with the largest defect sustained an implant failure in the distal femur and finally accomplished therapy by segmental transport. He also had the lowest uptake of fluoride of the patient collective (2.2-fold increase). Conclusion: Stem cell concentrates can be an alternative to segmental bone transport. Further studies are needed to compare this method with autologous bone grafting and segmental transport.
KW - Mesenchymal stem cells (MSC)
KW - Scaffold
KW - Segmental bone defect
KW - Stem cell concentrate
UR - http://www.scopus.com/inward/record.url?scp=84887169162&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84887169162&partnerID=8YFLogxK
U2 - 10.1007/s00264-013-2087-y
DO - 10.1007/s00264-013-2087-y
M3 - Article
C2 - 24013459
AN - SCOPUS:84887169162
SN - 0341-2695
VL - 37
SP - 2231
EP - 2237
JO - International Orthopaedics
JF - International Orthopaedics
IS - 11
ER -